Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.89M | 1.17M | 114.52K | 0.00 | 371.08K | 0.00 | Gross Profit |
1.82M | 1.12M | -107.70K | 0.00 | 86.76K | 0.00 | EBIT |
-7.80M | -10.17M | -7.53M | -146.31K | ― | ― | EBITDA |
-9.16M | -10.09M | -19.97M | -146.31K | ― | ― | Net Income Common Stockholders |
-9.94M | -10.34M | -6.77M | -146.31K | ― | ― |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.05K | 35.70K | 379.35K | 13.44K | 14.26K | 35.09K | Total Assets |
14.05K | 1.86M | 1.38M | 13.44K | 14.26K | 35.09K | Total Debt |
0.00 | 1.46M | 750.63K | 0.00 | 40.00K | ― | Net Debt |
-14.05K | 1.42M | 371.28K | -13.44K | 25.74K | ― | Total Liabilities |
276.58K | 4.77M | 2.55M | 403.46K | 252.24K | 191.12K | Stockholders Equity |
― | -2.90M | -1.17M | -390.03K | ― | ― |
Cash Flow | Free Cash Flow | ||||
-4.44M | -9.24M | -15.65M | 5.31K | ― | ― | Operating Cash Flow |
-4.44M | -9.24M | -15.43M | 5.31K | ― | ― | Investing Cash Flow |
-499.28K | -145.29K | -229.52K | 0.00 | -15.65K | 0.00 | Financing Cash Flow |
5.04M | 9.23M | 16.02M | -6.11K | 699.36K | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $1.42B | 16.74 | 14.76% | 4.34% | 8.11% | 15.83% | |
69 Neutral | $9.58B | 10.75 | 16.00% | 4.16% | -3.59% | 432.46% | |
68 Neutral | C$11.28B | 19.49 | 23.36% | ― | 23.03% | 81.01% | |
68 Neutral | C$4.59B | 157.81 | -0.10% | ― | 14.85% | -105.25% | |
57 Neutral | $20.94B | 10.43 | -13.41% | 2.52% | 4.53% | -23.34% | |
50 Neutral | $2.64B | ― | -7.59% | ― | -26.72% | 77.64% | |
42 Neutral | ― | 162.73% | ― | 130.24% | 8.72% |
Cybeats Technologies Corp. has announced two new strategic contracts with healthcare organizations, strengthening its position in the SBOM management market, particularly in the medical device manufacturing sector. The company reported a 148% net revenue retention rate for 2024 and over $7 million in total contract commitments, showcasing strong financial performance and market growth. Cybeats is also enhancing its product offerings and brand presence, and will participate in the S4x25 cybersecurity conference to further expand its pipeline and industry influence.
Cybeats Technologies Corp. has signed a significant three-year contract with Rockwell Automation to provide their SBOM Studio for software supply chain management. This agreement highlights Cybeats’ expanding influence in the industrial control systems sector, emphasizing the growing demand for robust software supply chain solutions across critical industries. The contract with Rockwell Automation reinforces Cybeats’ position as a trusted provider of complex product security solutions and supports organizations in streamlining software vulnerability management and regulatory compliance.
Cybeats Technologies Corp. is experiencing strong commercial growth with over $7 million in contract commitments and a 72% increase in customer spending in 2024, highlighting its leadership in the SBOM management market. The company raised $1.65 million to enhance its sales and marketing infrastructure, positioning it well to capitalize on the increasing demand for SBOM solutions as organizations prioritize software supply chain security. With a focus on healthcare and manufacturing sectors, Cybeats aims to deliver long-term value to its clients and investors.
Cybeats Technologies Corp. has secured a significant contract with a top global medical device manufacturer, marking its fourth such client in the sector. This partnership highlights the growing demand for Cybeats’ SBOM Studio, driven by regulatory pressures and the need for enhanced cybersecurity in the medical field.
Cybeats Technologies Corp. has bolstered its advisory board with the addition of cybersecurity experts Kurt Callewaert and Bob Haack. Their extensive experience will help Cybeats enhance its software supply chain security and navigate complex regulatory landscapes. These appointments underscore Cybeats’ commitment to innovation and leadership in the cybersecurity sector.
Cybeats Technologies Corp. has appointed Sophic Capital as its investor relations partner to enhance investor awareness and communicate its growth strategy effectively. This collaboration aims to leverage Sophic’s capital markets expertise to introduce Cybeats to a broader investment community as the company addresses global cybersecurity challenges. The partnership includes a financial agreement involving a monthly fee and stock options.
Cybeats Technologies Corp. has announced a non-brokered private placement offering to raise up to $5 million by selling 31.25 million units of the company. Each unit includes a common share and a warrant, with the funds aimed at bolstering sales, marketing, and working capital. This move replaces a previous financing plan to enhance flexibility and align with long-term goals.
Cybeats Technologies Corp. is poised to capitalize on the U.S. Army’s new mandate for Software Bills of Materials (SBOMs), enhancing software security and transparency. Their SBOM Consumer product is designed to help organizations like the Army manage and validate SBOMs, ensuring compliance and improving security measures. With this development, Cybeats positions itself as a strategic partner in strengthening the U.S. military’s software supply chain security.